Physician profile
Bradley E Wilcox
NPI 1760401657
$7,191.13
in general payments reported to CMS, 2019-2025
14 companies · $62.45 in 2025
The $62.45 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,032 · 2020: $4,833 · 2021: $464 · 2022: $141 · 2023: $329 · 2024: $330 · 2025: $62.45.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $722.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $722.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,426.02 | 2019-2024 | Da Vinci Surgical System |
| Ethicon INC. | $137.00 | 2019 | |
| Genzyme Corporation | $121.83 | 2024 | |
| La Jolla Pharmaceutical Company | $109.09 | 2023 | Giapreza |
| Abiomed | $78.97 | 2023-2024 | Impella |
| Inari Medical, INC. | $71.32 | 2022 | |
| Erbe USA INC | $56.00 | 2023 | Erbe Vio3 |
| Amgen INC. | $48.26 | 2025 | Tezspire |
| Davol INC. | $46.37 | 2022 | |
| Galvanize Therapeutics, INC | $37.78 | 2023 | Aliya System |
| Boston Scientific Corporation | $15.64 | 2023 | Coredx |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.90 | 2019 | |
| Insmed, INC. | $14.19 | 2025 | Arikayce |
| Siemens Medical Solutions USA, INC. | $13.76 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bradley Wilcox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.